|
BioGaia AB - Company Profile Snapshot
| Company Profile: |
BioGaia AB |
| Ticker: |
BIOG-B |
| Exchanges: |
STO |
| 2008 Sales: |
145,190,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
SWEDEN |
| Employees: |
42 |
Business Description
BioGaia AB. The Group's principal activities are the research, development and manufacturing of probiotic systems that build health in humans and animals. The products of the Group are based on the lactic acid bacterium Lactobacillus reuteri in combination with delivery systems that make it possible to create products with a long shelf life. Reuteri that has probiotic or health-enhancing effects occurs naturally in the intestinal flora of humans and animals. It inhibits the proliferation of harmful bacteria and promotes the growth of the normal intestinal microflora, thereby strengthening the immune system. The trademarks of the Group include Reuteri (R), LifeTop Straw and LifeTop Cap.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
